Portfolio holding Tandem Diabetes Care just received an important nod from the FDA, positioning the company for future significant growth. Read More
Stephen Leeb, Ph.D. is the Chief Investment Strategist of The Complete Investor and Real World Investing.
Dr. Leeb’s books have been notable for predicting the secular bull market that started in the 1980s (Getting in on the Ground Floor, Putnam, 1986); the tech stock crash and rise of real assets, including oil and gold (Defying the Market: Profiting in the Turbulent Post-Technology Market Boom, McGraw-Hill, 1999); and the surge in oil prices (The Oil Factor: Protect Yourself and Profit from the Coming Energy Crisis, Warner Books, 2004). His national bestseller, The Coming Economic Collapse: How You Can Thrive When Oil Costs $200 a Barrel (Warner Books, 2006), co-authored with Glen Strathy, outlined the biggest challenges facing the US economy, and accurately predicted the 2008 sub prime mortgage crisis as well as the vicious subsequent economic cycle requiring massive infusions of government stimulus, near zero interest rates and much higher federal debt levels. Game Over: How You Can Prosper in a Shattered Economy (Business Plus, 2009) predicted a permanent peak in global commodity production. Dr. Leeb’s eighth and latest book, Red Alert (Hachette, 2011), outlined China’s growing prosperity and the ways in which its demands on increasingly scarce resources threaten the American way of life.
Among his many speaking engagements, he has been the keynote speaker at both a JPMorgan Chase energy conference and a Royal Bank of Canada commodities conference.
Dr. Leeb received his bachelor’s degree in Economics from the University of Pennsylvania’s Wharton School of Business. He then earned his master’s degree in Mathematics and Ph.D. in Psychology from the University of Illinois in just three years, an academic record that stands to date. He is frequently quoted in the financial media, including Investors Business Daily, USA Today, Business Week, The New York Times, NPR and The Wall Street Journal. In addition, Dr. Leeb is a regular guest on Fox News, Bloomberg, CNN and Neil Cavuto.
Analyst Articles
Gold has proved once again that it's a safe haven during times of uncertainty. But its recent strength is just the beginning. Read More
Rising commodity prices hurt the American consumer, but here's how investors can profitably leverage commodity inflation. Read More
Following a favorable FDA ruling and the launch of new products, this medical device maker is pumping on all cylinders. Read More
The "red metal" is poised for a big jump in demand from electric vehicles and renewable energies, making it a multi-year investment opportunity. Read More
Biotech portfolio holding Lineage Cell Therapeutics is making progress in clinical trials with its drug candidates. Here's an update. Read More
This provider of energy efficiency solutions enjoys a healthy backlog that bodes well for future profits. Read More
Perhaps the best way to view the stock is as a long-term option on a potentially disruptive technology. Lots of catalysts could send the shares soaring. Read More
Sell to close the SPDR Gold Shares (GLD) March 15, 2019 $116 call option. Roll over the Franco-Nevada (FNV) January 18, 2019 $75 call option into the FNV January 17, 2020 $75 call. Pay no more than $5.30 on the January 2020 call. I recommend taking the gain… Read More
Malibu Boats once again posted exceptional operating results, reaffirming our long-term faith in the stock. Read More